[2025-10-01T07:52:52.218342] [QUERYOME] Starting research for query 1312: 'Instructions: 
 Answer the question below. First, respond with the single best option letter (A, B, C, or D). Then provide a concise reasoning (1–3 sentences). Use both the retrieved evidence and your own medical knowledge to choose the most accurate answer. 

Question:
Phase 1 clinical trial is done for: 

Options:
{'A': 'Drug safety', 'B': 'Pharmacodynamics', 'C': 'Efficacy', 'D': 'Dosing'}'
[2025-10-01T07:52:52.285799] [PI] Starting research for query: 'Instructions: 
 Answer the question below. First, respond with the single best option letter (A, B, C, or D). Then provide a concise reasoning (1–3 sentences). Use both the retrieved evidence and your own medical knowledge to choose the most accurate answer. 

Question:
Phase 1 clinical trial is done for: 

Options:
{'A': 'Drug safety', 'B': 'Pharmacodynamics', 'C': 'Efficacy', 'D': 'Dosing'}'
[2025-10-01T07:52:52.287627] Saving text to bench_final/run1/medmcqa/medmcqa_1311/pi_initial_prompt.txt
[2025-10-01T07:52:52.295504] [PI] Calling o3 for initial analysis...
[2025-10-01T07:52:55.319225] [PI] Reasoning iteration 1
[2025-10-01T07:52:55.321561] [PI] Executing function call 1: hybrid_search
[2025-10-01T07:52:55.332618] [PI] Function arguments: {'query': 'Phase 1 clinical trial main objective safety', 'k': 5, 'faiss_weight': 0.6, 'bm25_weight': 0.4, 'use_rrf': True}
[2025-10-01T07:52:55.335557] Saving JSON to bench_final/run1/medmcqa/medmcqa_1311/pi_iteration_1_tool_call_3_hybrid_search.json
[2025-10-01T07:53:32.446075] [PI] Function hybrid_search executed successfully
[2025-10-01T07:53:32.447775] Saving JSON to bench_final/run1/medmcqa/medmcqa_1311/pi_iteration_1_tool_result_3_hybrid_search.json
[2025-10-01T07:53:32.457692] [PI] Continuing reasoning with 1 function responses...
[2025-10-01T07:53:46.270115] [PI] Reasoning iteration 2
[2025-10-01T07:53:46.271930] [PI reasoning] **Determining maximum tolerated dose**

I'm examining the goal of determining the maximum tolerated dose (MTD) with a primary focus on safety during dose escalation. I'm considering which option aligns — could it be 'Drug safety,' 'Pharmacodynamics,' 'Efficacy,' or 'Dosing'? Phase I trials prioritize safety, tolerability, and pharmacokinetics, typically highlighting drug safety and dosage. When asked to choose one option, it usually relates to drug safety in the context of determining safe dose ranges during clinical trials. So, my instinct says Phase I is all about safety.
[2025-10-01T07:53:46.275033] [PI] No function calls found in response
[2025-10-01T07:53:46.276802] [PI] No more function calls - research complete
[2025-10-01T07:53:46.278449] Saving text to bench_final/run1/medmcqa/medmcqa_1311/pi_final_answer.txt
[2025-10-01T07:53:46.301181] [QUERYOME] Query completed successfully
